Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma

Study Title
Efficacy/Safety Study of Nebulized IVX-0142, a Novel AntiFemale, Maleergic Drug, in Mild Female, Maleergic Asthma
Teva Identifier
IXR-201-04-142
ClinicalTrials.gov Identifier
NCT00232999
Study Status
Completed
Trial Condition(s)
Asthma
Interventions
Drug: Nebulized IVX-0142

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 60 Years
Trial Duration
10/01/2005 - 01/01/2006
Phase
Phase 2

Study Type

Interventional